Abstract and Introduction
Purpose of Review: Many surgical treatment options are available for patients who present with benign prostatic obstruction (BPO). This article reviews the current treatment options available and distinguishes them based on five clinical considerations: antithrombotic therapy, sexual function preservation, ambulatory procedures, anesthesia-related risks and duration of catheterization.
Recent Findings: A comprehensive review of the literature was performed on 10 BPO procedures. Laser enucleation of the prostate (LEP), bipolar plasma transurethral vaporization of the prostate and photoselective vaporization (PVP) of the prostate reduces the risk of bleeding, which is recommended for anticoagulated men. Ejaculatory function is more likely to be preserved following transurethral incision of the prostate, Rezūm, Aquablation, UroLift and iTind. Same-day discharge is possible for LEP, PVP and prostatic arterial embolization (PAE). For patients with high anesthesia-related risks, procedures compatible with local anesthesia (UroLift, Rezūm, iTind and PAE) should be favored. Catheterization duration is shorter with UroLift, PVP and LEP.
Summary: BPO treatment options are growing rapidly. The optimal procedure for a given patient is based on factors such as associated risks, recovery and expected outcomes. Besides prostate volume, the clinical considerations in the present article can help elucidate the best surgical BPO treatment option for each patient based on their values, preferences, and risk tolerance.
As men age, it is common for them to experience benign prostatic obstruction (BPO), which may require surgery. The rapidly expanding surgical options available for patients requires shared decision-making to determine which procedure is the most appropriate. Prostate volume is a notable and objectifiable factor that guides the decision of which procedure the patient should undergo. However, there are other factors to consider in order to select the most appropriate technique for a given patient, such as those compatible with (1) antithrombotic therapy, (2) sexual (ejaculatory) function preservation, (3) same-day discharge, (4) local anesthesia (for high anesthesia-risk patients) and (5) duration of catheterization (Table 1).
The following review aims to categorize the numerous currently available treatment modalities according to the above clinical considerations and help the decision-making process for both patient and urologist. English articles were screened on PubMed for content on the 10 procedures reviewed and the 5 clinical considerations.
Curr Opin Urol. 2022;32(1):102-108. © 2022 Wolters Kluwer Health, Inc.